Prevalence of antibody seroconversion to Toxoplasma gondii in uveitis and non-uveitis dogs
dc.contributor.author | Kosec, G | |
dc.contributor.author | Hacin, B | |
dc.contributor.author | Sansom, PG | |
dc.contributor.author | Weaver, G | |
dc.contributor.author | Dewhurst, E | |
dc.contributor.author | Carter, JW | |
dc.date.accessioned | 2019-05-14T14:25:59Z | |
dc.date.issued | 2019-05-03 | |
dc.description.abstract | Objectives To evaluate the prevalence of seroconversion to Toxoplasma gondii in dogs with uveitis and dogs without uveitis. Methods In total, 135 dogs were evaluated: 51 dogs were diagnosed with uveitis, and 84 dogs were without uveitis. Latex agglutination tests were performed on all sera, and the results were evaluated. Results Overall, 7.8 and 6.0 per cent of sera were positive for the presence of anti-T gondii antibodies (dilution ≥1:64) in the groups with uveitis and non-uveitis dogs, respectively. The frequency distribution of variables (positive and negative results in the uveitis and the non-uveitis group of dogs) was tested with Fisher’s exact test. There was no statistically significant difference between groups (P=0.73). Clinical significance These findings suggest that evidence of exposure to T gondii was not significantly different between uveitis and non-uveitis groups of dogs and that the possible association between exposure to T gondii and canine uveitis requires further investigation. This study is the first to report the seroprevalence of anti-T gondii antibodies in dogs in the UK population and the first to report the seroprevalence of anti-T gondii antibodies in dogs with uveitis. | en_GB |
dc.identifier.citation | Vol. 6, article e000318 | en_GB |
dc.identifier.doi | 10.1136/vetreco-2018-000318 | |
dc.identifier.uri | http://hdl.handle.net/10871/37093 | |
dc.language.iso | en | en_GB |
dc.publisher | BMJ Publishing Group | en_GB |
dc.rights | © British Veterinary Association 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/ | en_GB |
dc.title | Prevalence of antibody seroconversion to Toxoplasma gondii in uveitis and non-uveitis dogs | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-05-14T14:25:59Z | |
dc.description | This is the final version. Available on open access from BMJ Publishing Group via the DOI in this record | en_GB |
dc.description | Data sharing statement: No additional data are available. | en_GB |
dc.identifier.journal | Veterinary Record Open | en_GB |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | en_GB |
dcterms.dateAccepted | 2019-02-13 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2019-05-03 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-05-14T13:00:21Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2019-05-14T14:26:04Z | |
refterms.panel | B | en_GB |
refterms.depositException | publishedGoldOA |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © British Veterinary Association 2019. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/